Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

Under the arrangement, prices for GLP-1 drugs—used both for diabetes and obesity—will be slashed for Medicare and Medicaid ...
Becker's Hospital Review

Medicare to cover GLP-1s under Trump-negotiated pricing

Medicare cover GLP-1s under a Trump-negotiated pricing plan starting in 2026, lowering costs for key obesity and diabetes drugs.
ConsumerAffairs

Medicare negotiates new prices for Ozempic and Wegovy

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...
MedPage Today on MSN

Medicare to Cover Blockbuster Obesity Drugs

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Medicare to Cover GLP-1 Drugs for as Little as $50 a Month Under Trump Plan

Seniors could soon pay just $50 a month for Ozempic and other drugs used for weight loss under a new Trump plan to cut prescription costs.
Opinion

Medicare Can’t Afford Not To Cover Ozempic

America's obesity epidemic costs an estimated $173 billion each year. The benefits of covering GLP-1s vastly outweigh the costs.